Solvency II ORSA, QIS5, IMAP, Omnibus II, EIOPA

European supervisors have relaxed the Solvency II reporting deadlines, but in return insurers have been asked to include analysis of the Covid-19 impacts on their business. David Walker reports on what those discussions might entail

Three lines of defence: a necessity or a nuisance?

The three lines of defence model has become a fixture for enterprise risk management in the insurance sector. But after nearly two decades since its introduction, does the model still have a place within the insurance industry or are changes needed? Paul Walsh investigates

UK actuaries take another crack at equity-release mortgage valuation

Valuation of equity-release mortgages (ERMs) is one of the most controversial topics in the UK actuarial community, and the latest update from the working party only makes a small step towards resolving the debate. Christopher Cundy reports

AAIC's ERM journey: inspired by Europe

AAIC's CRO Lorie Graham started the company's ERM programme in 2008 at a time when the US reinsurance sector had few models to look at. So she took her inspiration from the Europeans, she tells Sarfraz Thind

Eiopa hits back at the French ICS revolution

Some prominent French re/insurers don't want the Insurance Capital Standard in its current form, angering EU and US negotiators alike. Eiopa looks determined to carry on regardless. The IAIS is treading carefully. It is a fraught situation and some practitioners believe the standard could even collapse under its own weight, as Sarfraz Thind reports

IFRS 17 and Solvency II: clashes on discount curve and risk margin come to the fore

InsuranceERM's IFRS 17 conference heard insurers are keen to leverage much of what they have implemented for Solvency II in their IFRS 17 compliance programmes, but are struggling with certain elements. Paul Walsh and Christopher Cundy report

More Solvency II Analysis >